Earnings Call · Q2 FY2025·2025-08-01

Q2 25EPS +52.63%·Rev n/aQ1 25EPS +21.43%·Rev n/aQ4 24EPS -38.58%·Rev n/aQ3 24EPS +41.38%·Rev n/a⚠ consensus missing

CORCEPT THERAPEUTICS INC CORT

Atabak Mokari — Chief Financial Officer

Sean Maduck — President of Endocrinology Division

Gary Charles Robb — Chief Business Officer

Joseph K. Belanoff — CEO

−3.9%1d on move date−3.5% vs SPY3d+2.7%5d+0.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CORT calls or request research access.

More CORT calls Browse calls Request research access